Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 90

1.

Genetic defects in cytolysis in macrophage activation syndrome.

Zhang M, Behrens EM, Atkinson TP, Shakoory B, Grom AA, Cron RQ.

Curr Rheumatol Rep. 2014 Sep;16(9):439. doi: 10.1007/s11926-014-0439-2.

PMID:
25086802
[PubMed - in process]
2.

Clinical features, treatment and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis A multinational, multicenter study of 362 patients.

Minoia F, Davì S, Horne A, Demirkaya E, Bovis F, Li C, Lehmberg K, Weitzman S, Insalaco A, Wouters C, Shenoi S, Espada G, Ozen S, Anton J, Khubchandani R, Russo R, Pal P, Kasapcopur O, Miettunen P, Maritsi D, Merino R, Shakoory B, Alessio M, Chasnyk V, Sanner H, Gao Y, Huasong Z, Kitoh T, Avcin T, Fischbach M, Frosch M, Grom A, Huber A, Jelusic M, Sawhney S, Uziel Y, Ruperto N, Martini A, Cron RQ, Ravelli A; on behalf of the Pediatric Rheumatology International Trials Organization; the Childhood Arthritis & Rheumatology Research Alliance; the Pediatric Rheumatology Collaborative Study Group, and the Histiocyte Society.

Arthritis Rheumatol. 2014 Jul 30. doi: 10.1002/art.38802. [Epub ahead of print]

PMID:
25077692
[PubMed - as supplied by publisher]
3.

Biomarkers in systemic juvenile idiopathic arthritis: a comparison with biomarkers in cryopyrin-associated periodic syndromes.

Nirmala N, Grom A, Gram H.

Curr Opin Rheumatol. 2014 Sep;26(5):543-52. doi: 10.1097/BOR.0000000000000098.

PMID:
25050926
[PubMed - in process]
4.

Whole exome sequencing reveals overlap between macrophage activation syndrome in systemic juvenile idiopathic arthritis and familial hemophagocytic lymphohistiocytosis.

Kaufman KM, Linghu B, Szustakowski JD, Husami A, Yang F, Zhang K, Filipovich A, Fall N, Harley JB, Nirmala NR, Grom AA.

Arthritis Rheumatol. 2014 Jul 21. doi: 10.1002/art.38793. [Epub ahead of print]

PMID:
25047945
[PubMed - as supplied by publisher]
5.

Macrophage activation syndrome and cytokine-directed therapies.

Schulert GS, Grom AA.

Best Pract Res Clin Rheumatol. 2014 Apr;28(2):277-92. doi: 10.1016/j.berh.2014.03.002. Review.

PMID:
24974063
[PubMed - indexed for MEDLINE]
6.

A6: Tapering and Withdrawal of Tocilizumab in Patients With Systemic Juvenile Idiopathic Arthritis in Inactive Disease: Results From an Alternative Dosing Regimen in the TENDER Study.

De Benedetti F, Ruperto N, Brunner H, Grom AA, Wulffraat N, Henrickson M, Jerath R, Kimura Y, Kadva AK, Wang J, Martini A, Lovell DJ.

Arthritis Rheumatol. 2014 Mar;66 Suppl 11:S8-9. doi: 10.1002/art.38417.

PMID:
24677984
[PubMed - in process]
7.

A130: Is the CCR5-delta32 Mutation Protective Against Systemic-Onset Juvenile Idiopathic Arthritis?

Chasnyk V, Fedorova E, Egorov A, Ammosova T, Nekhai S, Kostik M, Santimov A, Dubko M, Kalashnikova O, Masalova V, Likhacheva T, Snegireva L, Grom A.

Arthritis Rheumatol. 2014 Mar;66 Suppl 3:S171. doi: 10.1002/art.38551.

PMID:
24677884
[PubMed - in process]
Free PMC Article
8.

Follistatin-like protein 1 and the ferritin/erythrocyte sedimentation rate ratio are potential biomarkers for dysregulated gene expression and macrophage activation syndrome in systemic juvenile idiopathic arthritis.

Gorelik M, Fall N, Altaye M, Barnes MG, Thompson SD, Grom AA, Hirsch R.

J Rheumatol. 2013 Jul;40(7):1191-9. doi: 10.3899/jrheum.121131. Epub 2013 May 15.

PMID:
23678162
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Gene-expression signatures differ between different clinical forms of familial hemophagocytic lymphohistiocytosis.

Sumegi J, Nestheide SV, Barnes MG, Villanueva J, Zhang K, Grom AA, Filipovich AH.

Blood. 2013 Feb 14;121(7):e14-24. doi: 10.1182/blood-2012-05-425769. Epub 2012 Dec 20.

PMID:
23264592
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis.

Ruperto N, Brunner HI, Quartier P, Constantin T, Wulffraat N, Horneff G, Brik R, McCann L, Kasapcopur O, Rutkowska-Sak L, Schneider R, Berkun Y, Calvo I, Erguven M, Goffin L, Hofer M, Kallinich T, Oliveira SK, Uziel Y, Viola S, Nistala K, Wouters C, Cimaz R, Ferrandiz MA, Flato B, Gamir ML, Kone-Paut I, Grom A, Magnusson B, Ozen S, Sztajnbok F, Lheritier K, Abrams K, Kim D, Martini A, Lovell DJ; PRINTO; PRCSG.

N Engl J Med. 2012 Dec 20;367(25):2396-406. doi: 10.1056/NEJMoa1205099.

PMID:
23252526
[PubMed - indexed for MEDLINE]
Free Article
11.

Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis.

De Benedetti F, Brunner HI, Ruperto N, Kenwright A, Wright S, Calvo I, Cuttica R, Ravelli A, Schneider R, Woo P, Wouters C, Xavier R, Zemel L, Baildam E, Burgos-Vargas R, Dolezalova P, Garay SM, Merino R, Joos R, Grom A, Wulffraat N, Zuber Z, Zulian F, Lovell D, Martini A; PRINTO; PRCSG.

N Engl J Med. 2012 Dec 20;367(25):2385-95. doi: 10.1056/NEJMoa1112802.

PMID:
23252525
[PubMed - indexed for MEDLINE]
Free Article
12.

Algorithm development for corticosteroid management in systemic juvenile idiopathic arthritis trial using consensus methodology.

Ilowite NT, Sandborg CI, Feldman BM, Grom A, Schanberg LE, Giannini EH, Wallace CA, Schneider R, Kenney K, Gottlieb B, Hashkes PJ, Imundo L, Kimura Y, Lang B, Miller M, Milojevic D, O'Neil KM, Punaro M, Ruth N, Singer NG, Vehe RK, Verbsky J, Woodward A, Zemel L.

Pediatr Rheumatol Online J. 2012 Aug 29;10(1):31. doi: 10.1186/1546-0096-10-31.

PMID:
22931206
[PubMed]
Free PMC Article
13.

Do adult disease severity subclassifications predict use of cyclophosphamide in children with ANCA-associated vasculitis? An analysis of ARChiVe study treatment decisions.

Morishita K, Guzman J, Chira P, Muscal E, Zeft A, Klein-Gitelman M, Uribe AG, Abramson L, Benseler SM, Eberhard A, Ede K, Hashkes PJ, Hersh AO, Higgins G, Imundo LF, Jung L, Kim S, Kingsbury DJ, Lawson EF, Lee T, Li SC, Lovell DJ, Mason T, McCurdy D, O'Neil KM, Punaro M, Ramsey SE, Reiff A, Rosenkranz M, Schikler KN, Scuccimarri R, Singer NG, Stevens AM, van Mater H, Wahezi DM, White AJ, Cabral DA; ARChiVe Investigators Network.

J Rheumatol. 2012 Oct;39(10):2012-20. doi: 10.3899/jrheum.120299. Epub 2012 Aug 1.

PMID:
22859342
[PubMed - indexed for MEDLINE]
14.

The limited role of interferon-γ in systemic juvenile idiopathic arthritis cannot be explained by cellular hyporesponsiveness.

Sikora KA, Fall N, Thornton S, Grom AA.

Arthritis Rheum. 2012 Nov;64(11):3799-808. doi: 10.1002/art.34604.

PMID:
22740319
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Increased sensitivity of the European medicines agency algorithm for classification of childhood granulomatosis with polyangiitis.

Uribe AG, Huber AM, Kim S, O'Neil KM, Wahezi DM, Abramson L, Baszis K, Benseler SM, Bowyer SL, Campillo S, Chira P, Hersh AO, Higgins GC, Eberhard A, Ede K, Imundo LF, Jung L, Kingsbury DJ, Klein-Gitelman M, Lawson EF, Li SC, Lovell DJ, Mason T, McCurdy D, Muscal E, Nassi L, Rabinovich E, Reiff A, Rosenkranz M, Schikler KN, Singer NG, Spalding S, Stevens AM, Cabral DA; ARegistry for Children with Vasculitis e-entry (ARChiVe) Network.

J Rheumatol. 2012 Aug;39(8):1687-97. Epub 2012 May 15.

PMID:
22589257
[PubMed - indexed for MEDLINE]
16.

Multiple juvenile idiopathic arthritis subtypes demonstrate proinflammatory IgG glycosylation.

Ercan A, Barnes MG, Hazen M, Tory H, Henderson L, Dedeoglu F, Fuhlbrigge RC, Grom A, Holm IA, Kellogg M, Kim S, Adamczyk B, Rudd PM, Son MB, Sundel RP, Foell D, Glass DN, Thompson SD, Nigrovic PA.

Arthritis Rheum. 2012 Sep;64(9):3025-33. doi: 10.1002/art.34507.

PMID:
22549726
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment.

Ravelli A, Grom AA, Behrens EM, Cron RQ.

Genes Immun. 2012 Jun;13(4):289-98. doi: 10.1038/gene.2012.3. Epub 2012 Mar 15. Review.

PMID:
22418018
[PubMed - indexed for MEDLINE]
18.

Assessing the performance of the Birmingham Vasculitis Activity Score at diagnosis for children with antineutrophil cytoplasmic antibody-associated vasculitis in A Registry for Childhood Vasculitis (ARChiVe).

Morishita K, Li SC, Muscal E, Spalding S, Guzman J, Uribe A, Abramson L, Baszis K, Benseler S, Bowyer S, Campillo S, Chira P, Hersh AO, Higgins G, Eberhard A, Ede K, Imundo L, Jung L, Kim S, Kingsbury DJ, Klein-Gitelman M, Lawson EF, Lovell DJ, Mason T, McCurdy D, Nanda K, Nassi L, O'Neil KM, Rabinovich E, Ramsey SE, Reiff A, Rosenkranz M, Schikler K, Stevens A, Wahezi D, Cabral DA; ARChiVe Investigators Network.

J Rheumatol. 2012 May;39(5):1088-94. doi: 10.3899/jrheum.111030. Epub 2012 Feb 15.

PMID:
22337238
[PubMed - indexed for MEDLINE]
19.

Update on the pathogenesis and treatment of systemic idiopathic arthritis.

Sikora KA, Grom AA.

Curr Opin Pediatr. 2011 Dec;23(6):640-6. doi: 10.1097/MOP.0b013e32834cba24. Review.

PMID:
22045308
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Gene Expression Profiles from Peripheral Blood Mononuclear Cells Are Sensitive to Short Processing Delays.

Barnes MG, Grom AA, Griffin TA, Colbert RA, Thompson SD.

Biopreserv Biobank. 2010 Sep 29;8(3):153-162.

PMID:
21743826
[PubMed]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk